Works matching DE "PROGRAMMED cell death 1 receptors"

Results: 5000

Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical Trial.

Published in:

JAMA: Journal of the American Medical Association, 2025, v. 333, n. 18, p. 1589, doi. 10.1001/jama.2025.1132

By:

Liang, Ye-Lin;
Liu, Xu;
Shen, Liang-Fang;
Hu, Guang-Yuan;
Zou, Guo-Rong;
Zhang, Ning;
Chen, Chuan-Ben;
Chen, Xiao-Zhong;
Zhu, Xiao-Dong;
Yuan, Ya-Wei;
Yang, Kun-Yu;
Jin, Feng;
Hu, Wei-Han;
Xie, Fang-Yun;
Huang, Ying;
Han, Fei;
Tang, Ling-Long;
Mao, Yan-Ping;
Lu, Li-Xia;
Sun, Rui

Publication type:

Article

Anti-PD-1 antibody enhances homeostatic proliferation–induced antitumor immunity during lymphopenia recovery.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1563894

By:

Yang, Zike;
Zhu, Ying;
Wang, Qian;
Lin, Qing;
Liu, Yahui

Publication type:

Article

Use of sintilimab in primary adenosquamous carcinoma of the liver results in pathological complete response: a case report and literature review.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1578368

By:

Bai, Zhiqing;
Chen, Yu-Ann;
Xiao, Ying;
Song, Jianping;
Song, Jianwei;
Xiang, Canhong

Publication type:

Article

Efficacy and Safety of Combined PD-1 Inhibitor with Induction Chemotherapy Followed by IMRT Plus Nimotuzumab in Locally Advanced Nasopharyngeal Carcinoma: A Retrospective Analysis [Corrigendum].

Published in:

2025

By:

Chen, Kebin;
Huang, Xiaopeng;
Chen, Jiawei;
Zhang, Shuai

Publication type:

Correction Notice

IL-11/IL-11R signal inhibition by 9MW3811 remodels immune tumor microenvironment and enhances anti-tumor efficacy of PD-1 blockade.

Published in:

NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-00913-w

By:

Zhang, Chang;
Jiao, Shasha;
Zeng, Dadi;
Jiang, Wen;
Wang, Rongjuan;
Zheng, Bin;
Wang, Min;
Wang, Shuang;
Gui, Xun

Publication type:

Article

Paricalcitol promotes the maturation of immune granulomas in an experimental model of superoxide dismutase A-induced inflammation.

Published in:

Inflammation Research, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00011-025-02050-3

By:

ET, Ablyakimov;
MA, Kriventsov;
AV, Kubyshkin;
Kriventsov, Maxim A.

Publication type:

Article

Immunotherapy benefits PD‑L1‑positive gastric‑type endocervical adenocarcinoma: A multicenter, retrospective study.

Published in:

Molecular & Clinical Oncology, 2025, v. 22, n. 6, p. N.PAG, doi. 10.3892/mco.2025.2841

By:

Li, Jing;
Wang, Dian;
Su, Ning;
Wang, Min;
Wang, Yulu

Publication type:

Article

N-glycosylation of PD-L1 modulates the efficacy of immune checkpoint blockades targeting PD-L1 and PD-1.

Published in:

Molecular Cancer, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12943-025-02330-w

By:

Kaufman, Bar;
Abu-Ahmad, Muhammad;
Radinsky, Olga;
Gharra, Eman;
Manko, Tal;
Bhattacharya, Baisali;
Gologan, Daniela;
Erlichman, Nofar;
Meshel, Tsipi;
Nuta, Yoav;
Cooks, Tomer;
Elkabets, Moshe;
Ben-Baruch, Adit;
Porgador, Angel

Publication type:

Article

Intrathecal administration of PD-1 inhibitor combined with pemetrexed for leptomeningeal metastases from breast cancer: a case report.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1567324

By:

Huang, Yushan;
Yang, Guozi;
Liu, Miaomiao;
Tai, Panpan;
Chen, Xiao;
Liu, Min;
Pan, Zhenyu

Publication type:

Article

Prior corticosteroid treatment alters cPBMC composition and IFNγ response to immunotherapy in canine cancer.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1544949

By:

Zimmermann, Anna Barbara Emilia;
Taskoparan, Betül;
Fuchs, Daniel;
Pantelyushin, Stanislav;
Maheswaran, Mathischan;
Schnyder, Manuela;
Hartnack, Sonja;
Rohrer Bley, Carla;
vom Berg, Johannes

Publication type:

Article

Spatial transcriptomics reveals tumor microenvironment heterogeneity in EBV positive diffuse large B cell lymphoma.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-00410-x

By:

He, Mei-yao;
Liu, Meng;
Yuan, Jiayin;
Lv, Jin;
Li, Wei;
Yan, Qianwen;
Tang, Yujiao;
Wang, Luyi;
Guo, Li;
Liu, Fang

Publication type:

Article

Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis.

Published in:

Indian Journal of Pharmacology, 2022, v. 54, n. 3, p. 183, doi. 10.4103/ijp.ijp_1089_20

By:

Deepak, H;
Prince, Sabina;
Deshpande, Pratima

Publication type:

Article

Smart Phototheranostics based on Carbon Nanohorns for Precise Imaging‐Guided Post‐PDT toward Residual Tumor Cells after Initial Phototherapy.

Published in:

Chemistry - A European Journal, 2023, v. 29, n. 8, p. 1, doi. 10.1002/chem.202203196

By:

Zhang, Hengming;
Zhu, Chengyuan;
Liang, Jiawei;
Li, Shuzhen;
Hu, Lan‐Fang;
Liang, Hong;
Kuo, Wen‐Shuo;
Shen, Xing‐Can

Publication type:

Article

Tuning of structural, optical, and impedance properties of CeO2 thin films by incorporation palladium ions.

Published in:

Journal of Materials Science: Materials in Electronics, 2020, v. 31, n. 13, p. 10031, doi. 10.1007/s10854-020-03547-9

By:

Ali, Syed Mansoor;
Khan, Salah Ud-Din;
AlGarawi, M. S.;
AlGamdi, S. S.

Publication type:

Article

Nanobody against PDL1.

Published in:

Biotechnology Letters, 2020, v. 42, n. 5, p. 727, doi. 10.1007/s10529-020-02823-2

By:

Li, Shufeng;
Jiang, Kunpeng;
Wang, Ting;
Zhang, Wei;
Shi, Minke;
Chen, Baojun;
Hua, Zichun

Publication type:

Article

Labeling IL-18 with alkaloids: toward the use of cytokines as carrier molecules in chemotherapy.

Published in:

Theoretical Chemistry Accounts: Theory, Computation, & Modeling, 2019, v. 138, n. 8, p. N.PAG, doi. 10.1007/s00214-019-2483-5

By:

Banegas-Luna, Antonio J.;
Peña-García, Jorge;
Contreras-García, Julia;
Pérez-Sánchez, Horacio;
Cerón-Carrasco, José P.

Publication type:

Article

PD-L1 importance in malignancies comprehensive insights into the role of PD-L1 in malignancies: from molecular mechanisms to therapeutic opportunities.

Published in:

Clinical & Experimental Medicine, 2025, v. 25, n. 1, p. 1, doi. 10.1007/s10238-025-01641-y

By:

Soltani, Mojdeh;
Abbaszadeh, Mohammad;
Fouladseresht, Hamed;
Sullman, Mark J. M.;
Eskandari, Nahid

Publication type:

Article

The multifaceted nature of diabetes mellitus induced by checkpoint inhibitors.

Published in:

Acta Diabetologica, 2019, v. 56, n. 12, p. 1239, doi. 10.1007/s00592-019-01402-w

By:

Marchand, Lucien;
Disse, Emmanuel;
Dalle, Stéphane;
Reffet, Sophie;
Vouillarmet, Julien;
Fabien, Nicole;
Thivolet, Charles;
Cugnet-Anceau, Christine

Publication type:

Article

Soluble programmed death-1 ligand 1(sPD-L1) is significantly reduced in the serum of type 1 diabetes patients.

Published in:

Acta Diabetologica, 2018, v. 55, n. 5, p. 515, doi. 10.1007/s00592-017-1081-z

By:

Chen, Xiaohong;
Guo, Heming;
Li, Sicheng;
Liu, Cuiping;
Ding, Sisi;
Huang, Yun;
Fang, Chen;
Hu, Ji

Publication type:

Article

Possibility of PD-1/PD-L1 Inhibitors for the Treatment of Patients with Chronic Hepatitis B Infection.

Published in:

Digestive Diseases, 2024, v. 42, n. 1, p. 53, doi. 10.1159/000534535

By:

Su, Menghan;
Ye, Ting;
Wu, Wei;
Shu, Zheyue;
Xia, Qi

Publication type:

Article

Dynamics of Soluble Forms of the Immune Checkpoint Components PD-1/PD-L1/B7-H3, CD314/ULBP1, and HLA-G in Peripheral Blood of Melanoma Patients Receiving Blockers of Programmed Cell Death Protein PD-1.

Published in:

Bulletin of Experimental Biology & Medicine, 2023, v. 175, n. 4, p. 481, doi. 10.1007/s10517-023-05891-2

By:

Gershtein, E. S.;
Mochalova, A. S.;
Korotkova, E. A.;
Samoilova, E. V.;
Vashketova, O. I.;
Kuz'min, Yu.B.;
Sokolov, N. Yu.;
Kushlinskii, N. E.

Publication type:

Article

Expression and Content of Protein LC3B in Gastric Cancer Tissue, Relationship with Expression of mTOR, AMPK in Gastric Cancer Tissue and HER2 and PD-L1 Status of the Tumor.

Published in:

Bulletin of Experimental Biology & Medicine, 2021, v. 172, n. 2, p. 202, doi. 10.1007/s10517-021-05376-0

By:

Spirina, L. V.;
Avgustinovich, A. V.;
Afanas'ev, S. G.;
Volkov, M. Yu.;
Kondakova, I. V.

Publication type:

Article

AKT/mTOR Signal Cascade and Expression of PD-1, PD-L1, and PD-L2 in Gastric Cancer.

Published in:

Bulletin of Experimental Biology & Medicine, 2020, v. 170, n. 1, p. 75, doi. 10.1007/s10517-020-05007-0

By:

Spirina, L. V.;
Avgustinovich, A. V.;
Afanas'ev, S. G.;
Kondakova, I. V.;
Volkov, M. Yu.;
Dobrodeev, A. Yu.;
Boronkina, A. I.

Publication type:

Article

Effects of Tussilago farfara L. Polysaccharides on the Expression of PD-1 (CD279) and PD-L1 (CD274) in Peripheral Blood and Tumor Tissue Lymphocytes in Mice with Lewis Lung Carcinoma.

Published in:

Bulletin of Experimental Biology & Medicine, 2020, v. 169, n. 3, p. 378, doi. 10.1007/s10517-020-04891-w

By:

Safonova, E. A.;
Lopatina, K. A.;
Razina, T. G.;
Zueva, E. P.;
Gur'ev, A. M.;
Belousov, M. V.

Publication type:

Article

Pan-cancer analyses of senescence-related genes in extracellular matrix characterization in cancer.

Published in:

Discover Oncology, 2023, v. 14, n. 1, p. 1, doi. 10.1007/s12672-023-00828-7

By:

Yan, Bo;
Liao, Pan;
Shi, Liqiu;
Lei, Ping

Publication type:

Article

Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays.

Published in:

NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00442-4

By:

Wang, Danyi;
Elenbaas, Brian;
Murugesan, Karthikeyan;
Shah, Kunal;
Montesion, Meagan;
Gounaris, Ioannis;
Scheuenpflug, Juergen;
Locatelli, Giuseppe;
Feng, Zheng

Publication type:

Article

PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127<sup>+</sup> and KLRG1<sup>+</sup> CD8 T cells.

Published in:

NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00384-x

By:

Hui, Zhenzhen;
Ren, Yulin;
Zhang, Dong;
Chen, Yulong;
Yu, Wenwen;
Cao, Jie;
Liu, Liang;
Wang, Tao;
Xiao, Shanshan;
Zheng, Liuqing;
Pu, Yue;
Wei, Feng;
You, Jian;
Ren, Xiubao

Publication type:

Article

Small extracellular vesicle PD-L1 in cancer: the knowns and unknowns.

Published in:

NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00287-3

By:

Yu, Zi-Li;
Liu, Jin-Yuan;
Chen, Gang

Publication type:

Article

Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade.

Published in:

NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00244-6

By:

Wang, Shuhang;
Yuan, Pei;
Mao, Beibei;
Li, Ning;
Ying, Jianming;
Tao, Xiuli;
Tang, Wei;
Zhang, Lei;
Geng, Xiao;
Zhang, Fan;
Xue, Qi;
Wu, Lijia;
Zhang, Henghui;
Gao, Shugeng;
He, Jie

Publication type:

Article

Nivolumab-induced eosinophilic fasciitis: a case report.

Published in:

2020

By:

Ollier, Natasha;
Tournier, Emilie;
Meyer, Nicolas;
Sibaud, Vincent;
Pages-Laurent, Cécile;
Cougoul, Pierre;
Beyne-Rauzy, Odile;
Comont, Thibault

Publication type:

Letter to the Editor

Endocrine Disruption.

Published in:: Journal of the Endocrine Society, 2022, v. 6, p. A430, doi. 10.1210/jendso/bvac150
Publication type:: Article

Response Rate and Survival at Key Timepoints With PD-1 Blockade vs Chemotherapy in PD-L1 Subgroups: Meta-Analysis of Metastatic NSCLC Trials.

Published in:

JNCI Cancer Spectrum, 2021, v. 5, n. 3, p. 1, doi. 10.1093/jncics/pkab012

By:

Man, Johnathan;
Millican, Jared;
Mulvey, Arthur;
Gebski, Val;
Hui, Rina

Publication type:

Article

Case report of an ST-elevation Myocardial Infarction-like presentation of an immune checkpoint (PD-1/PD-L1) inhibitor-associated myocarditis.

Published in:

European Heart Journal Case Reports, 2024, v. 8, n. 9, p. 1, doi. 10.1093/ehjcr/ytae429

By:

Declercq, Astrid;
Verstraete, Stefan;
Vanwalleghem, Lieve;
Trenson, Sander

Publication type:

Article

Artificial intelligence for chimeric antigen receptor-based therapies: a comprehensive review of current applications and future perspectives.

Published in:

Therapeutic Advances in Vaccines & Immunotherapy, 2024, v. 12, p. 1, doi. 10.1177/25151355241305856

By:

Shahzadi, Muqadas;
Rafique, Hamad;
Waheed, Ahmad;
Naz, Hina;
Waheed, Atifa;
Zokirova, Feruza Ravshanovna;
Khan, Humera

Publication type:

Article

Multiple myeloma and the potential of new checkpoint inhibitors for immunotherapy.

Published in:

Therapeutic Advances in Vaccines & Immunotherapy, 2024, v. 12, p. 1, doi. 10.1177/25151355241288453

By:

Kamali, Ali N.;
Hamedifar, Haleh;
Eisenhut, Michael;
Bautista, Jose M.

Publication type:

Article

An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer.

Published in:

Non-Coding RNA, 2023, v. 9, n. 6, p. 70, doi. 10.3390/ncrna9060070

By:

Martinez-Castillo, Moises;
M. Elsayed, Abdelrahman;
López-Berestein, Gabriel;
Amero, Paola;
Rodríguez-Aguayo, Cristian

Publication type:

Article

MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy.

Published in:

Non-Coding RNA, 2019, v. 5, n. 1, p. 1, doi. 10.3390/ncrna5010025

By:

Ogawa, Daisuke;
Ansari, Khairul;
Nowicki, Michal O.;
Salińska, Elżbieta;
Bronisz, Agnieszka;
Godlewski, Jakub

Publication type:

Article

Clinical characteristics, treatment, and outcomes of nivolumab-induced uveitis.

Published in:

Immunopharmacology & Immunotoxicology, 2025, v. 47, n. 2, p. 222, doi. 10.1080/08923973.2025.2461056

By:

Wu, Zhaoquan;
Sun, Wei;
He, Binsheng;
Wang, Chunjiang

Publication type:

Article

Tumor cells inhibit the activation of ILC2s through up-regulating PD-1 expression.

Published in:

Immunopharmacology & Immunotoxicology, 2024, v. 46, n. 3, p. 417, doi. 10.1080/08923973.2024.2347315

By:

Yin, Chaoyun;
Pa, Yani;
Li, Guangyu;
Chen, Qiang;
Wang, Xizu;
He, Xijun;
Zhou, Huangao

Publication type:

Article

Prediction of prognostic and immune therapy response in lung adenocarcinoma based on MHC-I-related genes.

Published in:

Immunopharmacology & Immunotoxicology, 2024, v. 46, n. 1, p. 93, doi. 10.1080/08923973.2023.2261146

By:

Xu, Hangdi;
Hu, Yanjie;
Peng, Xiuming;
Chen, Enguo

Publication type:

Article

Investigation of the therapeutic potential of recombinant bispecific bivalent anti-PD-L1/VEGF nanobody in inhibition of angiogenesis.

Published in:

Immunopharmacology & Immunotoxicology, 2023, v. 45, n. 2, p. 197, doi. 10.1080/08923973.2022.2131571

By:

Hassanzadeh Eskafi, Ayda;
Oghalaei, Akbar;
Mahboudi, Fereidoun;
Ghaderi, Hajarsadat;
Behdani, Mahdi;
Shoari, Alireza;
Kazemi-Lomedasht, Fatemeh

Publication type:

Article

2-methoxyestradiol inhibits melanoma cell growth by activating adaptive immunity.

Published in:

Immunopharmacology & Immunotoxicology, 2022, v. 44, n. 4, p. 541, doi. 10.1080/08923973.2022.2062380

By:

Hua, Weitian;
Huang, Xingfeng;
Li, Jingyu;
Feng, Wei;
Sun, Yi;
Guo, Chengrui

Publication type:

Article

(−)-4-O-(4-O-β-D-glucopyranosylcaffeoyl) quinic acid enhanced the efficacy of anti-PD-L1 against esophageal carcinoma through inhibiting PI3K pathway.

Published in:

Immunopharmacology & Immunotoxicology, 2021, v. 43, n. 6, p. 806, doi. 10.1080/08923973.2021.1990315

By:

Song, GuangLin;
Lu, YanLing;
Tang, LiNa;
Li, Min;
Yin, Jie;
Chen, HongMing;
Ling, JunDa

Publication type:

Article

Mycophenolate mofetil enhances the effects of tacrolimus on the inhibitory function of regulatory T cells in patients after liver transplantation via PD-1 and TIGIT receptors.

Published in:

Immunopharmacology & Immunotoxicology, 2021, v. 43, n. 2, p. 239, doi. 10.1080/08923973.2021.1891247

By:

Zeng, Qiang;
Yuan, Xiaoye;
Cao, Jinglin;
Zhao, Xin;
Wang, Yang;
Liu, Baowang;
Liu, Wenpeng;
Zhu, Zhijun;
Dou, Jian

Publication type:

Article

15-hydroxy-6α,12-epoxy-7β,10αH,11βH-spiroax-4-ene-12-one sensitizes rectal tumor cells to anti-PD1 treatment through agonism of CD11b.

Published in:

Immunopharmacology & Immunotoxicology, 2020, v. 42, n. 4, p. 358, doi. 10.1080/08923973.2020.1778722

By:

Zhao, Qingye;
Lu, Lin;
Du, Guowei;
Wang, Zhihai;
Li, Xutong;
Ju, Fang

Publication type:

Article

DRG2 is required for surface localization of PD-L1 and the efficacy of anti-PD-1 therapy.

Published in:

Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02027-x

By:

Choi, Seong Hee;
Mani, Muralidharan;
Kim, Jeonghwan;
Cho, Wha Ja;
Martin, Thomas F. J.;
Kim, Jee Hyun;
Chu, Hun Su;
Jeong, Won Jin;
Won, Young-Wook;
Lee, Byung Ju;
Ahn, Byungyong;
Kim, Junil;
Jeon, Do Yong;
Park, Jeong Woo

Publication type:

Article

Targeted immunotherapy: harnessing the immune system to battle multiple myeloma.

Published in:

Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-01818-6

By:

Xu, Limei;
Wen, Caining;
Xia, Jiang;
Zhang, Hao;
Liang, Yujie;
Xu, Xiao

Publication type:

Article

Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer.

Published in:

Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-023-01786-3

By:

Nunes, Sandra P.;
Morales, Lucia;
Rubio, Carolina;
Munera-Maravilla, Ester;
Lodewijk, Iris;
Suárez-Cabrera, Cristian;
Martínez, Victor G.;
Pérez-Escavy, Mercedes;
Pérez-Crespo, Miriam;
Alonso Sánchez, Miguel;
Montesinos, Esther;
San José-Enériz, Edurne;
Agirre, Xabier;
Prósper, Felipe;
Pineda-Lucena, Antonio;
Henrique, Rui;
Dueñas, Marta;
Correia, Margareta P.;
Jerónimo, Carmen;
Paramio, Jesús M.

Publication type:

Article

What happens to regulatory T cells in multiple myeloma.

Published in:

Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01765-8

By:

Chen, Huixian;
Wang, Xueling;
Wang, Yan;
Chang, Xiaotian

Publication type:

Article

STIM1 in tumor cell death: angel or devil?

Published in:

Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01703-8

By:

Ren, Ran;
Li, Yongsheng

Publication type:

Article